Safety and Tolerability of Repeat Doses of Serelaxin in Patients With Chronic Heart Failure: The RELAX-REPEAT Study

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2016.06.039
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2013English

Corrigendum to ‘Efficacy and Safety of Serelaxin When Added to Standard of Care in Patients With Acute Heart Failure: Results From a PROBE Study, RELAX‐AHF‐EU’ [Eur J Heart Fail 2019;21:322‐333]

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Defining a ‘Frequent Admitter’ Phenotype Among Patients With Repeat Heart Failure Admissions

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

The Landscape of DNA Repeat Elements in Human Heart Failure

Genome Biology
2012English

Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-Shift Study ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Tolerability, Safety, and Hemodynamics of Sacubitril-Valsartan in Acutely Decompensated Heart Failure Patients With Cardiogenic Shock

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Altered Regulation of Cardiac Ankyrin Repeat Protein in Heart Failure

Heliyon
Multidisciplinary
2018English

Efficacy and Safety of Goreisan for Chronic Heart Failure Patients With Chronic Kidney Disease

Kampo Medicine
2019English

Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy